Watson has announced its intention to acquire Actavis, the company said. Following news reports that the U.S.-based generic drug maker would acquire Switzerland-based Actavis, Watson announced that it would buy the latter for $5.6 billion.
An experimental kidney cancer drug made by Pfizer didn't extend the time in which patients survived without their disease worsening when compared with a competing drug, according to results of a late-stage clinical trial released Wednesday.
Concern over rising fuel prices has eclipsed unemployment — the leading worry since 2009 — as the No. 1 factor that keeps retailers up at night, according to a study released by BDO USA on Monday, though the current uptick in consumer spending somewhat alleviates that concern.
Social media ranks as one of those technologies that has changed the world in many ways, allowing networking across the world, sharing of thoughts and events from people’s lives, embarrassment of public figures and, more recently, even helping to feed political revolutions.
It’s been more than 200 years since the first successful test of a vaccine against smallpox, and since then, vaccines have become one of the most important means of preventing and eradicating infectious diseases, ranging from minor ailments like the flu to devastating ones like polio.
The American Association of Colleges of Pharmacy and the National Community Pharmacists Association announced the winners of a competition designed to highlight the best practices in medication adherence teaching among the nation's 127 colleges and schools of pharmacy.
Fuse Science on Tuesday announced that it has picked up distribution for its EnerJel product — a topical energy product targeting fitness fanatics — to 200 south Florida pharmacies through a partnership with GAT Trading.